121 related articles for article (PubMed ID: 9416405)
1. Comparison of positron emission tomography and computed tomography in detection of recurrent and metastatic colorectal cancer.
Cohen AM
Ann Surg Oncol; 1997 Dec; 4(8):610. PubMed ID: 9416405
[No Abstract] [Full Text] [Related]
2. Management of recurrent colorectal cancer with positron emission tomography.
Haji A
Br J Hosp Med (Lond); 2007 Nov; 68(11):580-3. PubMed ID: 18087843
[TBL] [Abstract][Full Text] [Related]
3. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography.
Ogunbiyi OA; Flanagan FL; Dehdashti F; Siegel BA; Trask DD; Birnbaum EH; Fleshman JW; Read TE; Philpott GW; Kodner IJ
Ann Surg Oncol; 1997 Dec; 4(8):613-20. PubMed ID: 9416407
[TBL] [Abstract][Full Text] [Related]
4. [Current status of nuclear medicine. Clinical application of FDG-PET for cancer diagnosis. Colorectal cancer].
Ito K; Kato T
Nihon Igaku Hoshasen Gakkai Zasshi; 2002 May; 62(6):270-7. PubMed ID: 12073633
[TBL] [Abstract][Full Text] [Related]
5. Whole-body PET proves superior to CT for staging primary colorectal carcinoma.
Ott DJ
Am J Gastroenterol; 1999 Jan; 94(1):285-6. PubMed ID: 9934781
[No Abstract] [Full Text] [Related]
6. [PET/CT in colorectal cancer].
Talbot JN
Rev Prat; 2010 Oct; 60(8):1074-7. PubMed ID: 21197736
[No Abstract] [Full Text] [Related]
7. A new imaging technique for colorectal cancer: positron emission tomography.
Flamen P; Van Cutsem E; Mortelmans L
Semin Oncol; 2000 Oct; 27(5 Suppl 10):22-9. PubMed ID: 11049029
[No Abstract] [Full Text] [Related]
8. Whole-body PET imaging with [18F]fluorodeoxyglucose in management of recurrent colorectal cancer.
Valk PE; Abella-Columna E; Haseman MK; Pounds TR; Tesar RD; Myers RW; Greiss HB; Hofer GA
Arch Surg; 1999 May; 134(5):503-11; discussion 511-3. PubMed ID: 10323422
[TBL] [Abstract][Full Text] [Related]
9. Value of 18F-fluoro-2-deoxyglucose positron emission tomography in the evaluation of recurrent colorectal cancer.
Hung GU; Shiau YC; Tsai SC; Chao TH; Ho YJ; Kao CH
Anticancer Res; 2001; 21(2B):1375-8. PubMed ID: 11396217
[TBL] [Abstract][Full Text] [Related]
10. The role of positron emission tomography in the management of colorectal cancer.
Tutt AN; Plunkett TA; Barrington SF; Leslie MD
Colorectal Dis; 2004 Jan; 6(1):2-9. PubMed ID: 14692944
[TBL] [Abstract][Full Text] [Related]
11. Endotracheal metastasis from colorectal cancer.
Tabacchi E; Ghedini P; Cambioli S; Castellucci P; Fanti S
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1335-6. PubMed ID: 25916743
[No Abstract] [Full Text] [Related]
12. Positron emission tomography in colorectal cancer.
Flamen P
Best Pract Res Clin Gastroenterol; 2002 Apr; 16(2):237-51. PubMed ID: 11969236
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of positron emission tomography by using F-18-fluorodeoxyglucose in diagnosis of recurrent colorectal cancer].
Kula Z; Szefer J; Zuchora Z; Romanowicz G; Pietrzak T
Pol Merkur Lekarski; 2004; 17 Suppl 1():63-6. PubMed ID: 15603351
[TBL] [Abstract][Full Text] [Related]
14. PET/CT in Colorectal Cancer.
Schiepers C
J Nucl Med; 2003 Nov; 44(11):1804-5. PubMed ID: 14602863
[No Abstract] [Full Text] [Related]
15. Positron emission tomography and colorectal carcinoma: an update.
Tzimas GN; Koumanis DJ; Meterissian S
J Am Coll Surg; 2004 Apr; 198(4):645-52. PubMed ID: 15051018
[No Abstract] [Full Text] [Related]
16. FDG positron emission tomography in colorectal cancer.
Tecnologica MAP Suppl; 2000 Jan; ():6-8. PubMed ID: 10848115
[No Abstract] [Full Text] [Related]
17. [Combined functional and morphological imaging with PET/CT systems].
Kaim AH; von Schulthess GK
Praxis (Bern 1994); 2003 Feb; 92(6):225-7. PubMed ID: 12645384
[No Abstract] [Full Text] [Related]
18. Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice.
Ruhlmann J; Schomburg A; Bender H; Oehr P; Robertz-Vaupel GM; Vaupel H; Wolter H; Kozak B; Biersack HJ
Dis Colon Rectum; 1997 Oct; 40(10):1195-204. PubMed ID: 9336115
[TBL] [Abstract][Full Text] [Related]
19. Clinical impact of fluorodeoxyglucose-positron emission tomography scan/computed tomography in comparison with computed tomography on the detection of colorectal cancer recurrence.
Deleau C; Buecher B; Rousseau C; Kraeber-Bodéré F; Flamant M; des Varannes SB; Frampas E; Galmiche JP; Matysiak-Budnik T
Eur J Gastroenterol Hepatol; 2011 Mar; 23(3):275-81. PubMed ID: 21304319
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of colorectal cancer with FDG-PET].
Uno K
Nihon Rinsho; 2003 Sep; 61 Suppl 7():168-72. PubMed ID: 14574875
[No Abstract] [Full Text] [Related]
[Next] [New Search]
